REVISITING THE NANGELI INCIDENT OF MYSORE
Al-Shodhana · 30.01.2026 · 14 (1) · 1-12
DOI: 10.70644/as.v14.i1.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Shodhana, online erschienen am 30.01.2026. Verfasst von Dr Mahimai Dass A. SDB. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Gender and caste issues have always formed significant part of the historical narratives of India, revealing unjustified hegemony and evoking empathy. For over two thousand years these social evils have retarded the progress of India by paralysing human resource both physically and intellectually. Although with modern education and global awareness some of the abominable practices of the past have been outlawed, even today one does not fail to come across episodes of heinous crimes committed against women based on their caste and gender. Women’s bodies are very often used as topographical maps to exercise power and dominance. It is in this pedagogical journey of exposing some of the controverted debates, this article attempts to revisit the hotly disputed incident of Nangeli in Travancore kingdom, and tries to add more substance to the existing subaltern-discourse. When the academic circle is divided over the historicity of the event, this article responds to those who brush aside its historicity on the claims of absence of such taxes in India. The article brings to light documentary evidence for breast tax in the kingdom of Mysore, and hence the possibility of its existence also in the kingdom of Travancore.
Zitieren
APA
SDB, D. M. D. A. (2026). REVISITING THE NANGELI INCIDENT OF MYSORE. Al-Shodhana, 14(1), 1-12. https://doi.org/10.70644/as.v14.i1.1
Vancouver
SDB DMDA. REVISITING THE NANGELI INCIDENT OF MYSORE. Al-Shodhana. 2026;14(1):1-12. doi:10.70644/as.v14.i1.1
BibTeX
@article{SDB2026,
author = {SDB, Dr Mahimai Dass A.},
title = {REVISITING THE NANGELI INCIDENT OF MYSORE},
journal = {Al-Shodhana},
year = {2026},
volume = {14},
number = {1},
pages = {1--12},
doi = {10.70644/as.v14.i1.1}
}
EUVIMED